Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Botulinum toxin A shows promise in the treatment of detrusor overactivity

Sep. 3, 2004

Yamanouchi submits YM-905 for approval in Japan

Sep. 2, 2004

Long-term improvement of urinary incontinence achieved with solifenacin

Sep. 2, 2004

Novel 17beta-HSD-3 inhibitors and their use claimed by Schering-Plough

Sep. 2, 2004

Cannabinoids found to improve urge incontinence in MS patients

Sep. 2, 2004

Good safety profile reported for darifenacin in OAB

Sep. 2, 2004

New selective beta3-adrenoceptor agonist in development at Mitsubishi

Aug. 31, 2004

Fesoterodine reduces micturition and urge incontinence in UFS

Aug. 31, 2004

Extended-release tolterodine shows efficacy for mixed incontinence in women

Aug. 31, 2004

Yamanouchi to roll out Vesicare in E.U.

Aug. 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...